Clinical trialNCT02516670TerminatedPhase 2Interventional

Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer

SponsorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrollment50Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaStage IV Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Channing Paller, MD
Johns Hopkins University/Sidney Kimmel Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
Anne Arundel Health System, Research Institute
Annapolis, Maryland, United States
Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
University Hospitals of Cleveland Seidman Cancer Center
Cleveland, Ohio, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Jun 2016
Primary completion: 31 Jul 2021
Completion: 14 Oct 2021
Last update posted: 7 Jun 2023
Registered enrollment: 50
Registry id: NCT02516670

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.